T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Biogen
BIIB
$30.9B
| $630M | 0.09% |
1,783,142
-190,489
| -10% | -$65.6M |
|
227
Atmos Energy
ATO
$28.7B
| $626M | 0.09% |
6,663,075
-719,400
| -10% | -$66.4M |
|
228
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.65B
| $619M | 0.09% |
481,109
+70,450
| +17% | +$90M |
|
|
PR
229
Permian Resources
PR
$18B
| $617M | 0.09% |
28,224,948
+1,633,381
| +6% | +$30.7M |
|
230
EQT Corp
EQT
$33.8B
| $616M | 0.09% |
25,587,376
+3,671,553
| +17% | +$101M |
|
231
Xcel Energy
XEL
$49.1B
| $615M | 0.09% |
13,028,310
+6,437,217
| +98% | +$304M |
|
|
PFPT
232
DELISTED
Proofpoint, Inc.
PFPT
| $609M | 0.09% |
5,722,778
+3,316,998
| +138% | +$386M |
|
|
FRC
233
DELISTED
First Republic Bank
FRC
| $606M | 0.09% |
6,308,243
-2,195,123
| -26% | -$221M |
|
234
Incyte
INCY
$24.5B
| $603M | 0.09% |
8,729,009
-2,261,619
| -21% | -$155M |
|
|
AET
235
DELISTED
Aetna Inc
AET
| $600M | 0.09% |
2,959,258
-3,990,867
| -57% | -$780M |
|
236
News Corp Class A
NWSA
$15.5B
| $598M | 0.09% |
45,352,266
-114,114
| -0.3% | -$1.6M |
|
237
Eli Lilly
LLY
$1.09T
| $593M | 0.09% |
5,530,147
+2,800,631
| +103% | +$280M |
|
|
ESRX
238
DELISTED
Express Scripts Holding Company
ESRX
| $577M | 0.08% |
6,074,699
+3,370,668
| +125% | +$287M |
|
239
Synchrony
SYF
$25.8B
| $575M | 0.08% |
18,503,691
+8,182,566
| +79% | +$261M |
|
240
Wabtec
WAB
$49.9B
| $574M | 0.08% |
5,477,450
-1,429,361
| -21% | -$154M |
|
|
HDS
241
DELISTED
HD Supply Holdings, Inc.
HDS
| $574M | 0.08% |
13,417,447
-2,607,022
| -16% | -$114M |
|
242
Booz Allen Hamilton
BAH
$9.43B
| $573M | 0.08% |
11,537,431
+526,712
| +5% | +$25.7M |
|
243
Simon Property Group
SPG
$71.4B
| $564M | 0.08% |
3,190,503
+264,592
| +9% | +$46.8M |
|
|
GLIBA
244
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $559M | 0.08% |
10,966,941
-20,987
| -0.2% | -$1.01M |
|
245
Stanley Black & Decker
SWK
$15.5B
| $557M | 0.08% |
3,801,959
-1,384,790
| -27% | -$197M |
|
246
Eversource Energy
ES
$26.9B
| $556M | 0.08% |
9,043,658
-4,195,693
| -32% | -$257M |
|
247
FirstEnergy
FE
$27.2B
| $552M | 0.08% |
14,846,541
-314,556
| -2% | -$11.5M |
|
248
CarGurus
CARG
$3.29B
| $548M | 0.08% |
9,845,831
-783,204
| -7% | -$36.2M |
|
|
RP
249
DELISTED
RealPage, Inc.
RP
| $546M | 0.08% |
8,292,348
+363,273
| +5% | +$21.7M |
|
250
Procter & Gamble
PG
$335B
| $543M | 0.08% |
6,521,866
+26,569
| +0.4% | +$2.17M |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.